Skip to main content

Empower Clinics Revenues Increase Substantially

3,000 Tests and appointments completed since June 1st add to increased revenue across divisions

VANCOUVER, BC / ACCESSWIRE / June 13, 2022 / EMPOWER CLINICS INC (CSE:CBDT)(Frankfurt:8EC)(OTCQB:EPWCF) ("Empower" or the "Company") an integrated healthcare company offering services in the U.S. and Canada - announced today its fully accredited healthcare practice in Vancouver, B.C. continues to dramatically expand adding to revenue growth across its divisions.

Since June 1st, the company has administered more than 3,000 tests and booked appointments, providing an essential service to travelers, tourists and adding employment to the local community. Empower previously announced that it had exceeded 3000 tests in only its first full month of operation in May 2022, while still early in the tourist season.

"I believe the continued growth in our testing business is a reflection of our commitment to our customers and clients - think of travelers, cruise ship companies, tour operators - that will use our fully accredited testing solutions," stated Steven McAuley, Chairman and CEO of Empower Clinics. "Our investment to be a fully accredited operation is paying off, as the dynamic and important cruiseship industry comes back and thrives in Vancouver." Mr. McAuley continues, "When we add these advancements to the progress of our other divisions, our growth continues, and we are achieving our goals."

Empower offers the most comprehensive fully accredited COVID-19 testing solutions in and around the Port of Vancouver and Canada Place. All of its sites are fully accredited by the College of Physicians and Surgeons of British Columbia's Diagnostic Accreditation Program (DAP). Its sites include three certified sites at the Port of Vancouver, Canada Place and Fairmont Waterfront Hotel as well as a recently accredited concierge mobile service. All COVID-19 testing in British Columbia requires accreditation by the College's Diagnostic Accreditation Program (DAP).

Empower's COVID-19 testing solutions are highlighted on the website for Royal Carribean - the world's second largest cruise operator. The Vancouver Fraser Port Authority expects more than 300 cruise ship calls for the 2022 season.

Passengers can visit to book COVID-19 testing solutions that include virtual (telehealth) or in-person Rapid Antigen / Rapid PCR (RT-Lamp) testing at a site at Fairmont Waterfront Hotel - adjacent to the port terminal at Canada Place. Pricing of solutions range from $100 CAD to $250 CAD per test.

This press release is available on the Empower Clinics Verified Forum on AGORACOM for shareholder discussion, questions and engagement with management


Empower is an integrated healthcare company that provides body and mind wellness for patients through its clinics, with digital and telemedicine care, a medical device company and world-class medical diagnostics laboratories. Supported by an experienced leadership team, Empower is aggressively growing its clinical and digital presence across North America. Our Health & Wellness and Diagnostics & Technology business units are positioned to positively impact the integrated health of our patients, while simultaneously providing long term value for our shareholders.


Steven McAuley
Chief Executive Officer



Steven McAuley CEO


Tamara Mason
Business Development & Communications


This news release contains certain "forward-looking statements" or "forward-looking information" (collectively "forward looking statements") within the meaning of applicable Canadian securities laws. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as at the date of this news release. Forward-looking statements can frequently be identified by words such as "plans", "continues", "expects", "projects", "intends", "believes", "anticipates", "estimates", "may", "will", "potential", "proposed" and other similar words, or information that certain events or conditions "may" or "will" occur. Forward looking statement in this press release include, that more than 300 cruise ships calls will take place in 2022. Such forwardlooking statements are based on assumptions known to management at this time, and are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward-looking statements, including: that the Company may be unable to enter into definitive agreements, or close transactions with respect to, proposed future clinic openings; that due diligence with respect to anticipated clinic openings and acquisitions may not be satisfactory to the Company; risks related to delays in permitting or construction; risks related to supply chains and access to labour; that legislative changes may have an adverse effect on the Company's business and product development; that the Company may not be able to obtain adequate financing to pursue its business plan; that the Company will be able to commence and/or complete build-outs and tenants improvements for new clinics; general business, economic, competitive, political and social uncertainties; and other factors beyond the Company's control. No assurance can be given that any of the events anticipated by the forward-looking statements will occur on the terms or in the time expected, or at all, or, if they do occur, what benefits the Company will obtain from them. Readers are cautioned not to place undue reliance on the forward-looking statements in this release, which are qualified in their entirety by these cautionary statements. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements in this release, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities laws.

SOURCE: Empower Clinics Inc.

View source version on

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.